Clinical practice patterns of lung stereotactic body radiation therapy in the united states: A secondary analysis

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 36, Issue 3, 2013, Pages 269-272

  Pan, Hubert ^a   Rose, Brent S ^a   Simpson, Daniel R ^a   Mell, Loren K ^a   Mundt, Arno J ^a   Lawson, Joshua D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

clinical practice patterns; lung neoplasms; stereotactic body radiotherapy; survey

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CORRELATION COEFFICIENT; HUMAN; LUNG CANCER; PHYSICIAN; RANDOM SAMPLE; SECONDARY ANALYSIS; STEREOTACTIC BODY RADIATION THERAPY; UNITED STATES;

DOSE FRACTIONATION; HUMANS; LUNG NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RADIOSURGERY; UNITED STATES;

EID: 84878877125     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e3182467db3     Document Type: Article

References (25)

1. Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol. 2007;30:637-644.
2. Timmerman RD, Kavanagh BD, Cho LC, et al. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol. 2007;25: 947-952.
3. Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303:1070-1076.
4. Bradley JD, El Naqa I, Drzymala RE, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys. 2010;77:1146-1150.
5. Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of riskadapted fractionated stereotactic radiotherapy for stage I nonsmall-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70: 685-692.
6. Nagata Y, Negoro Y, Aoki T, et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2002;52:1041-1046.
7. Takeda A, Sanuki N, Kunieda E, et al. Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys. 2009;73:442-448.
8. Videtic GM, Stephans K, Reddy C, et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys. 2010;77:344-349.
9. Nagata Y, Hiraoka M, Mizowaki T, et al. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group. Int J Radiat Oncol Biol Phys. 2009;75:343-347.
10. Pan H, Simpson DR, Mell LK, et al. A survey of stereotactic body radiotherapy use in the United States. Cancer. 2011;117:4566-4572.
11. Simpson DR, Lawson JD, Nath SK, et al. A survey of imageguided radiation therapy use in the United States. Cancer. 2010; 116:3953-3960.
12. Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the US, 2004. Cancer. 2005;104:1296-1303.
13. Fowler JF. Linear quadratics is alive and well: in regard to Park et al. (Int J Radiat Oncol Biol Phys 2008;70:847-852).
14. Int J Radiat Oncol Biol Phys. 2008;72:957; author reply 958.
15. Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847-852.
16. Hiraoka M, Matsuo Y, Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiother. 2007;11:32-35.
17. Jiang SB, Wolfgang J, Mageras GS. Quality assurance challenges for motion-adaptive radiation therapy: gating, breath holding, and four-dimensional computed tomography. Int J Radiat Oncol Biol Phys. 2008;71:S103-S107.
18. Keall PJ, Mageras GS, Balter JM, et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. Med Phys. 2006;33:3874-3900.
19. Negoro Y, Nagata Y, Aoki T, et al. The effectiveness of an immobilization device in conformal radiotherapy for lung tumor: reduction of respiratory tumor movement and evaluation of the daily setup accuracy. Int J Radiat Oncol Biol Phys. 2001;50:889-898.
20. De La Fuente Herman T, Vlachaki MT, Herman TS, et al. Stereotactic body radiation therapy (SBRT) and respiratory gating in lung cancer: dosimetric and radiobiological considerations. J Appl Clin Med Phys. 2010;11:158-169.
21. Keall PJ, Kini VR, Vedam SS, et al. Potential radiotherapy improvements with respiratory gating. Australas Phys Eng Sci Med. 2002;25:1-6.
22. Gagel B, Demirel C, Kientopf A, et al. Active breathing control (ABC): determination and reduction of breathing-induced organ motion in the chest. Int J Radiat Oncol Biol Phys. 2007;67:742-749.
23. Underberg RW, Lagerwaard FJ, Cuijpers JP, et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys. 2004;60: 1283-1290.
24. Murphy MJ. Fiducial-based targeting accuracy for external-beam radiotherapy. Med Phys. 2002;29:334-344.
25. Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable earlystage lung cancer. J Clin Oncol. 2006;24:4833-4839.